Trends Projected to Reshape the Healthcare Landscape in 2024
Several societal drivers will shape the healthcare landscape in 2024, including a longer-living population, transformative technologies, and global economic uncertainty. [...]
Podcast Q&A: Literature Reviews and Global Value Dossiers
This podcast segment features the Q&A from DistillerSR’s March 15, 2023 webinar with HealthEconomics.Com. Join Gillian Sibbring, Sue O’Leary, [...]
The Emerging Outcomes Demonstration / Cost Management Challenge
The current healthcare environment reshapes the three key factors in market access – value, evidence, and commercial positioning of [...]
Podcast Q&A: Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
This tHEORetically Speaking podcast episode highlights the Q&A from Genesis Research's October 20, 2022 webinar and features Priti Jhingran and [...]
Podcast: How Accelerated Drug Development Requires Disruption in Market Access and Pricing
We recently sat down with Preeti Patel, MPharm, CEO and Founder of Global Pricing Innovations (GPI), to learn what is [...]
How might digitization change health care in Germany by 2035, Julian Molitor?
Digital health could improve the efficiency, care and way patients are treated in all health care systems in the next [...]
Are selective contracts with German insurances a smarter reimbursement pathway, Tim Hering?
Within the opportunity of contracting in the German health care market, prices, reimbursement and integrated care paths could be agreed [...]
Would AI substitute or (only) support market access managers, Dr. Andree Bates?
Dr Stefan Walzer, market access expert, and his guest Dr. Andree Bates, expert in artificial intelligence (AI), are discussing the future [...]
How successful is the DiGA fast track, Dr. Henrik Matthies?
Dr. Matthies used to be at the epicenter of the DIGA launch in 2020. He was the managing director of [...]
The UK market access has always been complex, now even more than before, Graham Foxon and Paul Craddy?
The UK has always been on the forefront of market access with its unique pathways within England, but especially also considering Wales, [...]
Switzerland is strong in many aspects, so also in its health care system, Dr. Peter Indra?
The Swiss healthcare system is rather complex but at the same time quite effective. High expenditures into health care corresponds with [...]
AMNOG was the end of paradise for pharmaceutical companies, correct Prof. Hammerschmidt?
What have been the main changes after 10 years of AMNOG for pharmaceutical companies? What have been the biggest successes [...]
Podcast Q&A: Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations
This podcast segment from Self Care Catalysts' June 29, 2022 webinar features the Q&A with Renee Willmon, MSc, Senior Director, [...]
What is the secret of the cost-efficient healthcare system in Israel, Mirel Stelian?
Israel spends only 7.6% of the GDP on healthcare – significantly less than most other Western OECD countries. At the [...]
Dutch payers are pragmatic, especially when discussing medical devices, isn’t it, Ron de Graff?
The market access process in the Netherlands can be very special, especially for medical devices. Besides standard reimbursement processes with [...]
The Belgium reimbursement pathway for digital health applications is similarly easy as in Germany, correct Katrien de Groote?
Belgium has created a similar fast-track process as in Germany even though that some differences exist. Anyway, core question with [...]
Is European market access really so difficult? Tell us the truth about being successful in Europe, Esther Nzenza!
Europe is one continent, with one Union (plus the UK)… Health policy is still the responsibility of each individual country [...]
What can Europeans learn from Canada for the upcoming EU joint HTA, Gabriel Tremblay?
EU joint HTA will become reality in the next few years as communicated recently by the European Commission. However, applicability [...]
Differentiate Your Product From the Competition: Give Healthcare Decision Makers the Information They Need
In this competitive pharmaceutical market access landscape, payers are preparing budgets and financial forecasts well ahead of product launches, [...]
MArS Supplier Spotlight
Supplier Spotlight® highlights the unique skill sets and service offerings from organizations who are part of our CONNECTED COMMUNITY™. Below [...]
Does the Italian reimbursement pathway allow for innovative drugs being highly priced, Dr. Stefano Capri and Dr. Entela Xoxi?
The Italian reimbursement system is unique in terms of its structure, especially also for innovative drugs. However, what does the new innovation pathway means to the [...]
What are the specific elements about the Austrian market access pathway, Dr. Anna Bucsics?
The Austrian market access pathway in the outpatient setting is unique in its pragmatic approach with their box system. The [...]
The private health insurances as the entrance into German market access – is this true, Dr. Bastian Biermann?
The German health care system consists of the statutory and private health insurances, whereas the latter covers around 10% of [...]
How can a company derive the optimal price for their medical product, Dr. Renato, Dellamano?
What are drivers of pricing and ultimately negotiations? How can a global strategy best be implemented in individual countries? How [...]
How do innovations reach patients in German hospitals, Dr. Sebastian Casu?
How important are the famous NUBs, OPS and DRG values? How can innovations reach patients beyond administrative barriers? What are [...]
